Evidence map›Paper›PMID 36318289›Full record

ArticleAnnals of hematology2022

Acute fulminant intravascular hemolysis induced by Clostridium perfringens in a symptomatic multiple myeloma patient under immuno-chemotherapy.

Hideyuki Yamamoto, Yuki Mizutani, Chisako Iriyama, Naoe Goto, Akinao Okamoto, Toshiharu Kato, Chiyo Shintani, Naoki Yamamoto, Takahiko Miyama, Keichiro Mihara and 2 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Annals of hematology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Sepsis Caused byInfection and drug resistance · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Hideyuki YamamotoDepartment of Hematology, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan.
Yuki MizutaniDepartment of Clinical Laboratory, Fujita Health University School of Medicine, Toyoake, Japan.
Chisako IriyamaDepartment of Hematology, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan.
Naoe GotoDepartment of Hematology, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan.
Akinao OkamotoDepartment of Hematology, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan.
Toshiharu KatoDepartment of Hematology, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan.
Chiyo ShintaniDepartment of Clinical Laboratory, Fujita Health University School of Medicine, Toyoake, Japan.
Naoki YamamotoSupport Office for Bioresource Research, Research Promotion Headquarters, Fujita Health University, Toyoake, Japan.
Takahiko MiyamaInternational Center for Cell and Gene Therapy, Fujita Health University, Toyoake, Japan.
Keichiro MiharaInternational Center for Cell and Gene Therapy, Fujita Health University, Toyoake, Japan.
Masataka OkamotoDepartment of Oncology, Fujita Health University Okazaki Medical Center, Okazaki, Japan.
Akihiro TomitaDepartment of Hematology, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan. atomita@fujita-hu.ac.jp.ORCID 0000-0002-5391-1399
Fujita Health University · JPFujita Health University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Clostridium InfectionsMultiple MyelomaSepsisClostridium perfringensHemolysisHumansImmunotherapyAnti-CD38 monoclonal antibodiesClostridium perfringensIntravascular hemolysisMultiple myeloma

Identifiers

PMID36318289
OpenAlexW4307840144

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.